Meet Our Team
The People Behind PSI
Psychedelic Science Institute was founded by a multidisciplinary team of leaders in neuroscience, mental health, psychedelic medicine, and healthcare strategy, bringing together the expertise of the TRIP Center at Pacific Neuroscience Institute and the California Center for Psychedelic Therapy. Our physicians, psychologists, psychotherapists, psychiatric nurses, and research professionals are united by a shared commitment to advancing the science and responsible implementation of psychedelic medicines.


Since 2018, our team has delivered more than 12,000 ketamine-assisted psychotherapy (KAP) sessions and participated in multiple clinical trials evaluating investigational psychedelic medicines. Together, we are helping build the evidence, clinical expertise, and care delivery model needed to responsibly integrate these therapies into mainstream healthcare.
Founders
Daniel Kelly, MD
Chief Executive Officer

Keith Heinzerling, MD, MPH
Chief Medical & Science Officer

Brooke Balliett, LMFT
Chief Operating Officer

Micah Linton, PsyD
Chief Clinical & Innovation Officer

Gregory Kearns, MHA
Chief Strategy & Business Development Officer
Advisors
Kyle Moore, MHA
Strategic Finance Advisor

Divya Malhotra
Technology & Data Advisor

Mike Avila
Philanthropic Advisor

Our Team
Leah Bedrosian, MPH
Clinical Research Manager

Kyrsten Cardenas
Business Operations Manager

Jose Fregoso, MSN, PMHNP
Psychiatric Mental Health Nurse Practitioner

Taira Chaudry, PMHNP-BC
Psychiatric Mental Health Nurse Practitioner

Juliana N. Hudson, LCSW
Psychotherapist

Oliver Goldsmith
Senior Clinical Research Coordinator

Ashley Ramos
Senior Clinical Research Coordinator
Jamie Carrafa
Front Desk Coordinator

Dayra Alamo
Front Desk Coordinator
Ramon Elizondo, RN
Registered Nurse
